These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36846471)

  • 1. Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping.
    Marxreiter F; Lambrecht V; Mennecke A; Hanspach J; Jukic J; Regensburger M; Herrler J; German A; Kassubek J; Grön G; Müller HP; Laun FB; Dörfler A; Winkler J; Schmidt MA
    Ther Adv Neurol Disord; 2023; 16():17562864221143834. PubMed ID: 36846471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
    Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
    Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and Parkinsonism syndromes: Evaluating iron deposition in the putamen using magnetic susceptibility MRI techniques - A systematic review and literature analysis.
    Mohammadi S; Ghaderi S
    Heliyon; 2024 Apr; 10(7):e27950. PubMed ID: 38689949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative susceptibility mapping in atypical Parkinsonisms.
    Mazzucchi S; Frosini D; Costagli M; Del Prete E; Donatelli G; Cecchi P; Migaleddu G; Bonuccelli U; Ceravolo R; Cosottini M
    Neuroimage Clin; 2019; 24():101999. PubMed ID: 31539801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative susceptibility mapping differentiates between parkinsonian disorders.
    Sjöström H; Granberg T; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2017 Nov; 44():51-57. PubMed ID: 28886909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders.
    Zhang P; Chen J; Cai T; He C; Li Y; Li X; Chen Z; Wang L; Zhang Y
    Front Aging Neurosci; 2022; 14():909552. PubMed ID: 35992605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using 'swallow-tail' sign and putaminal hypointensity as biomarkers to distinguish multiple system atrophy from idiopathic Parkinson's disease: A susceptibility-weighted imaging study.
    Wang N; Yang H; Li C; Fan G; Luo X
    Eur Radiol; 2017 Aug; 27(8):3174-3180. PubMed ID: 28105503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY; Huang B; Yang WQ; Zhang YH; Wang LM; Wang LJ; Zhong XL
    Acta Radiol; 2015 Mar; 56(3):322-8. PubMed ID: 24619850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms.
    Mazzucchi S; Del Prete E; Costagli M; Frosini D; Paoli D; Migaleddu G; Cecchi P; Donatelli G; Morganti R; Siciliano G; Cosottini M; Ceravolo R
    Eur J Neurol; 2022 Oct; 29(10):2944-2955. PubMed ID: 35700041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of quantitative susceptibility mapping in multiple system atrophy: The impact of echo time and the potential of histogram analysis.
    Lancione M; Cencini M; Costagli M; Donatelli G; Tosetti M; Giannini G; Zangaglia R; Calandra-Buonaura G; Pacchetti C; Cortelli P; Cosottini M
    Neuroimage Clin; 2022; 34():102989. PubMed ID: 35303599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of T2* gradient echo, susceptibility-weighted imaging, and quantitative susceptibility mapping for patients with multiple system atrophy-parkinsonian type: a systematic review and meta-analysis.
    Lim SJ; Suh CH; Shim WH; Kim SJ
    Eur Radiol; 2022 Jan; 32(1):308-318. PubMed ID: 34272590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron deposition in subcortical nuclei of Parkinson's disease: A meta-analysis of quantitative iron-sensitive magnetic resonance imaging studies.
    Jin J; Su D; Zhang J; Lam JST; Zhou J; Feng T
    Chin Med J (Engl); 2024 May; ():. PubMed ID: 38809051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
    Krismer F; Seppi K; Göbel G; Steiger R; Zucal I; Boesch S; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Mov Disord; 2019 Jul; 34(7):1041-1048. PubMed ID: 30919495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying iron deposition in the cerebellar subtype of multiple system atrophy and spinocerebellar ataxia type 6 by quantitative susceptibility mapping.
    Sugiyama A; Sato N; Kimura Y; Fujii H; Maikusa N; Shigemoto Y; Suzuki F; Morimoto E; Koide K; Takahashi Y; Matsuda H; Kuwabara S
    J Neurol Sci; 2019 Dec; 407():116525. PubMed ID: 31639532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping.
    Ito K; Ohtsuka C; Yoshioka K; Kameda H; Yokosawa S; Sato R; Terayama Y; Sasaki M
    Neuroradiology; 2017 Aug; 59(8):759-769. PubMed ID: 28689259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swallow tail sign on susceptibility map-weighted imaging (SMWI) for disease diagnosing and severity evaluating in parkinsonism.
    Liu X; Wang N; Chen C; Wu PY; Piao S; Geng D; Li Y
    Acta Radiol; 2021 Feb; 62(2):234-242. PubMed ID: 32380911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
    Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
    Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
    Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
    Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism.
    Sjöström H; Surova Y; Nilsson M; Granberg T; Westman E; van Westen D; Svenningsson P; Hansson O
    Sci Rep; 2019 Apr; 9(1):6079. PubMed ID: 30988382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of 3D-PRESTO imaging in evaluating putaminal abnormality in parkinsonian variant of multiple system atrophy.
    Sakurai K; Kawaguchi T; Kawai T; Ogino H; Hara M; Okita K; Yamawaki T; Shibamoto Y
    Neuroradiology; 2010 Sep; 52(9):809-14. PubMed ID: 19894040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.